UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by First Financial Bankshares Inc

First Financial Bankshares Inc boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 38,193 shares of the healthcare conglomerate’s stock after purchasing an additional 112 shares during the quarter. First Financial Bankshares Inc’s holdings in UnitedHealth Group were worth $19,320,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Generali Investments Management Co LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at $2,258,000. Bank of Marin increased its position in UnitedHealth Group by 28.3% during the fourth quarter. Bank of Marin now owns 1,069 shares of the healthcare conglomerate’s stock worth $541,000 after purchasing an additional 236 shares during the last quarter. North Forty Two & Co. acquired a new position in UnitedHealth Group in the fourth quarter valued at $586,000. VSM Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth about $56,000. Finally, OVERSEA CHINESE BANKING Corp Ltd increased its position in shares of UnitedHealth Group by 23.0% in the fourth quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 49,145 shares of the healthcare conglomerate’s stock worth $24,892,000 after acquiring an additional 9,204 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $503.61 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The firm has a market cap of $460.66 billion, a PE ratio of 32.49, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company’s fifty day simple moving average is $510.90 and its 200-day simple moving average is $548.54.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm posted $5.83 EPS. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.67%. UnitedHealth Group’s payout ratio is 54.19%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on UNH. Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.